Medical News

RSS

Sweeping and prescriptive path to green nation's operating rooms

A sweeping and prescriptive path to green the nation's operating rooms was announced today by Practice Greenhealth, the nation's leading membership and networking organization for institutions in healthcare that have made a commitment to sustainable, eco-friendly practices.

12 May 2010

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

Spectranetics Corporation today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.

12 May 2010

CNA announces winners of 2010 CNA Employer Recognition Award

The Canadian Nurses Association announced today the winners of the 2010 CNA Employer Recognition Award. This prestigious prize honours employers who have shown an exceptional commitment to supporting registered nurses pursuing national certification in a range of nursing specialties.

12 May 2010

Liberator Medical Holdings reports net revenues of $9.65M for second fiscal quarter 2010

Liberator Medical Holdings, Inc. announced today net revenues of $9.65 million for its second fiscal quarter ended March 31, 2010. Net income for the three months ended March 31, 2010, increased by $161,000, or 169%, to $256,000, compared with net income of $95,000 for the three months ended March 31, 2009.

12 May 2010

Risk of venous thromboembolism is low after hepatic resection in cirrhotic patients: Researchers

Hepatocellular carcinoma is the most common primary neoplasm of the liver and often arises in the context of a chronic liver disease that impairs coagulative function. Surgical resection is the best option to cure HCC, however, surgery on cirrhotic liver may increase the risk of bleeding.

12 May 2010

Pro-Pharmaceuticals reports net loss applicable to common stock of $2.8M for first-quarter 2010

Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the first quarter, ended March 31, 2010.

12 May 2010

Capstone Therapeutics to continue to planned 12-month endpoints in AZX100 Phase 2a clinical trials

Capstone Therapeutics announced today it has completed a limited analysis of a subset of data from the second of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. The clinical trial will continue to its planned 12-month endpoints.

12 May 2010

DATATRAK International's first-quarter 2010 revenue decreased to $1,678,000

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced its operating results for the first quarter of 2010: $1.7 million revenue, $10.7 million backlog and 82% gross profit margin; all resulting in profitability.

12 May 2010

Bioniche third-quarter consolidated revenues increase 111% to $15.6 million

Bioniche Life Sciences Inc., a research-based, technology-driven Canadian biopharmaceutical company, today announced financial results for its Fiscal 2010 third quarter, ended March 31, 2010.

12 May 2010

Americans face new era in health insurance

With the passage of the Patient Protection and Affordable Care Act ("PPACA") and the Health Care and Education Reconciliation Act of 2010, Americans face a new era in health insurance.

12 May 2010

FDA approves Aeterna Zentaris' AEZS-108 IND for bladder cancer

Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its doxorubicin targeted conjugate compound, AEZS-108, in luteinizing hormone releasing hormone (LHRH) receptor positive urothelial (bladder) cancer.

12 May 2010

First Edition: May 12, 2010

Today's headlines include reports about new congressional budget office projections that increase the 10-year costs of the health overhaul law.

12 May 2010

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

Soligenix, Inc., a late-stage biopharmaceutical company, announced today that patient enrollment has been completed in a randomized, double-blind, placebo-controlled Phase 2 clinical trial of orBec for the prevention of acute Graft-versus-Host disease after allogeneic hematopoietic cell transplantation with myeloablative conditioning regimens.

12 May 2010

Merck hosts R&D and Business Briefing

Merck & Co., Inc. today hosted its first R&D and Business Briefing since the completion of the Merck and Schering-Plough merger. The event included a comprehensive review of the company's late-stage pipeline, as well as the company's commercial strategy and progress made in the integration of Merck's worldwide operations.

12 May 2010

Genetic variations do not improve ability to predict risk of AD: Study

Although genome-wide analysis identified two genetic variations associated with Alzheimer disease, these variations did not improve the ability to predict the risk of AD, according to a study in the May 12 issue of JAMA.

12 May 2010

Proposed cuts to New Jersey's tobacco control programs will increase teen smoking, healthcare costs

Proposed cuts to New Jersey's Comprehensive Tobacco Control Program may raise teen smoking and will increase costs to the state in the long run, said a former New Jersey health commissioner today.

12 May 2010

Minnesota Governor signs into law the Tobacco Modernization and Compliance Act of 2010

Today Minnesota's leading health groups applauded Governor Tim Pawlenty for taking another step to protect youth from harmful tobacco products. This afternoon, the Governor signed into law the Tobacco Modernization and Compliance Act of 2010, which updates Minnesota laws to address new generations of tobacco products.

12 May 2010

Registered nurses to march and rally in Washington to press for landmark patient safety legislation

Up to 1,000 registered nurses from Maine to California will march and rally in Washington, DC, today to press the case for moving beyond insurance reform to improving the quality of care in U.S. hospitals and other healthcare settings.

12 May 2010

Marriage raises life expectancy

Marriage is more beneficial for men than for women - at least for those who want a long life. Previous studies have shown that men with younger wives live longer. While it had long been assumed that women with younger husbands also live longer, in a new study Sven Drefahl from the Max Planck Institute for Demographic Research (MPIDR) in Rostock, Germany, has shown that this is not the case. Instead, the greater the age difference from the husband, the lower the wife's life expectancy.

12 May 2010

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

Investigators from around the country came to Sanford-Burnham Medical Research Institute (Sanford-Burnham) on Friday, May 7, to share their knowledge of the burgeoning young field of microRNAs. These small non-coding nucleic acids turn off proteins and have been implicated in viral infection, cancer, cardiovascular disease, HIV and numerous other conditions.

12 May 2010

Medical News

Sweeping and prescriptive path to green nation's operating rooms

Spectranetics to demonstrate new Laser Lead Extraction Simulation system at Heart Rhythm 2010

CNA announces winners of 2010 CNA Employer Recognition Award

Liberator Medical Holdings reports net revenues of $9.65M for second fiscal quarter 2010

Risk of venous thromboembolism is low after hepatic resection in cirrhotic patients: Researchers

Pro-Pharmaceuticals reports net loss applicable to common stock of $2.8M for first-quarter 2010

Capstone Therapeutics to continue to planned 12-month endpoints in AZX100 Phase 2a clinical trials

DATATRAK International's first-quarter 2010 revenue decreased to $1,678,000

Bioniche third-quarter consolidated revenues increase 111% to $15.6 million

Americans face new era in health insurance

FDA approves Aeterna Zentaris' AEZS-108 IND for bladder cancer

First Edition: May 12, 2010

Patient enrollment completed in Phase 2 clinical trial of orBec for prevention of acute GVHD

Merck hosts R&D and Business Briefing

Genetic variations do not improve ability to predict risk of AD: Study

Proposed cuts to New Jersey's tobacco control programs will increase teen smoking, healthcare costs

Minnesota Governor signs into law the Tobacco Modernization and Compliance Act of 2010

Registered nurses to march and rally in Washington to press for landmark patient safety legislation

Marriage raises life expectancy

Sanford-Burnham Scientific Symposium provides wealth of information on microRNAs, RNAi

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Latest News